Risk-Adapted Strategy Combining Magnetic Resonance Imaging and Prostate-Specific Antigen Density to Individualize Biopsy Decision in Patients With PI-RADS 3 ``Gray Zone'' Lesions
- Resource Type
- Article
- Source
- In
Clinical Genitourinary Cancer June 2024 22(3) - Subject
- Language
- ISSN
- 1558-7673